Antibe Therapeutics Inc.
TSX:ATE
C$ 0.30
C$0.00 (0.00%)
C$ 0.30
C$0.00 (0.00%)
End-of-day quote: 04/20/2024

ATE - Antibe Therapeutics Stock Prediction 2025 - 2030

11 years of reliable Antibe Therapeutics stock forecast. The Wall Street analysts predict Hold for ATE. See at a glance whether TSX:ATE will rise in the future.

C$0.00
Forecast 2023
C$0.00 C$0.32
Forecast 2025
C$0.51
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
C$0.00
Forecast 2025
C$0.00 C$0.32
Forecast 2030
C$0.51
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.19
Price-to-book Ratio
0.61
Market Cap
0.05B
TEV
0.02 B
Dividend
C$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
C$1.69
Country

Antibe Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Antibe Therapeutics Stock Forecast 2023

C$2.00

In the last five quarters, Antibe Therapeutics’s Price Target has fallen from C$1.75 to C$1.69 - a -3.43% decrease. Two analysts predict that Antibe Therapeutics’s share price will increase in the coming year, reaching C$2.00. This would represent an increase of 18.34%.

566.67%
566.67
Last update: 05/20/2024

Highest Price Target C$2.00

Average Price Target C$2.00

Lowest Price Target C$2.00

Antibe Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One Antibe Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of C$0.27. A decrease of -9.95% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of C$0.30. A decrease of -0.95% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of C$0.32. An increase of 8.06% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of C$0.33. An increase of 8.9% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of C$0.33. An increase of 9.75% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of C$0.33. An increase of 10.59% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of C$0.33. An increase of 11.43% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of C$0.34. An increase of 12.27% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of C$0.34. An increase of 13.12% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of C$0.34. An increase of 13.96% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of C$0.34. An increase of 14.8% compared to today's share price.

Stock Prediction for the Price of One Antibe Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of C$0.35. An increase of 15.65% compared to today's share price.

Antibe Therapeutics Stock Predictions 2030

Antibe Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of C$0.50. An increase of 66.62% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of C$0.50. An increase of 67.82% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of C$0.51. An increase of 69.03% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of C$0.51. An increase of 70.34% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of C$0.51. An increase of 71.66% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of C$0.52. An increase of 72.98% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of C$0.52. An increase of 74.3% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of C$0.53. An increase of 75.62% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of C$0.53. An increase of 76.94% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of C$0.53. An increase of 78.26% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of C$0.54. An increase of 79.57% compared to the previous month's estimate.

Antibe Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of C$0.54. An increase of 80.89% compared to the previous month's estimate.

P/E
0.00
Beta
0.19
Price-to-book Ratio
0.61
Market Cap
0.05B
TEV
0.02 B
Dividend
C$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
C$1.69
Country

Antibe Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Antibe Therapeutics Inc.?

The following analysts have recently covered Antibe Therapeutics:

Brookline Capital Markets
Maxim Group
Paradigm Capital, Inc.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Antibe Therapeutics Inc.?

The following sell-side analysts have recently covered Antibe Therapeutics:

Dolliver, Brian Kemp
Rahman, Nazibur
McAuley, Scott
(This information refers to the last 90 days.)